NCT06566976 Prehabilitation and Rehabilitation in PAD
| NCT ID | NCT06566976 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Palo Alto Veterans Institute for Research |
| Condition | Peripheral Arterial Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-03-07 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2024-03-07 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To determine the effectiveness of pre and post-operative exercise therapy in patients undergoing peripheral artery stenting for peripheral arterial disease.
Eligibility Criteria
Inclusion Criteria: * Male or Female adult diagnosed with peripheral artery disease (PAD) * Experiencing leg pain while walking * Scheduled to have a stent for PAD * Able to perform exercise safely * Postmenopausal and not of child bearing capacity Exclusion Criteria: * Medically unstable patients * Recent MI within 3 months * Malignancy * Uncontrolled diabetes mellitus (HBA1C ≥8 mmol/l) * Alcoholism or other recreational drug use
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06566976 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Peripheral Arterial Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06566976 currently recruiting?
Yes, NCT06566976 is actively recruiting participants. Contact the research team at drj993@aol.com for enrollment information.
Where is the NCT06566976 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT06566976 clinical trial?
NCT06566976 is sponsored by Palo Alto Veterans Institute for Research. The trial plans to enroll 300 participants.